NASUS PHARMA LTD

Historical 13F Holders

Symbol
NSRX
CUSIP
M7071P109
All holders as of
Q2 2026
Type
Equity
Class
ORD SHS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for M7071P109 since 12/18/2024, largest first.

Filer % of Class Filed
Udi Gilboa 13G 21.1% 11/10/2025
Event 9/30/2025
Megiddo Dalia 13G 20.9% 11/12/2025
Event 9/30/2025
Hershman Ronnie 13G
15.3% 11/13/2025
Event 9/30/2025
Balyasny Asset Management L.P. 13G/A
10.0% 8/14/2026
Event 6/30/2026
Capital Point Ltd. 13G 6.4% 8/20/2025
Event 8/14/2025
Funicular Funds, LP 13G
5.2% 4/7/2026
Event 3/31/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 10 2.15 M $7.53 M
2026 Q1 9 2.17 M $4.83 M
2025 Q4 2 2.38 k $21.8 k
2025 Q3 2 3.24 k $21.6 k